Seer Operating Margin 2020-2022 | SEER
Current and historical operating margin for Seer (SEER) over the last 10 years. The current operating profit margin for Seer as of March 31, 2022 is -794.43%.
| Seer Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2022-03-31 |
$0.01B |
$-0.08B |
-877.78% |
| 2021-12-31 |
$0.01B |
$-0.07B |
-1183.33% |
| 2021-09-30 |
$0.00B |
$-0.06B |
-2133.33% |
| 2021-06-30 |
$0.00B |
$-0.05B |
-5400.00% |
| 2021-03-31 |
$0.00B |
$-0.04B |
inf% |
| 2020-12-31 |
$0.00B |
$-0.03B |
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.613B |
$0.007B |
|
Seer Inc. is a life sciences company. It engages in developing Proteograph(TM), which is an integrated solution consisting of consumables, automation instrumentation and proprietary software. Seer Inc. is based in REDWOOD CITY, Calif.
|
